Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|February 7, 2003
The pulmonary renin-angiotensin systemRichard P Marshall
Biochimica Et Biophysica Acta|February 5, 2013
Strategies for biomarker discovery in fibrotic diseaseRichard P Marshall, Juliet K Simpson, Pauline T Lukey
Nature Reviews. Drug Discovery|September 5, 2015
Dissecting fibrosis: therapeutic insights from the small-molecule toolboxCarmel B Nanthakumar, Richard J D Hatley, Seble Lemma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory responseAnastasia Papafili, Michael R Hill, David J Brull, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 20, 2003
Angiotensin II and the fibroproliferative response to acute lung injuryRichard P Marshall, Peter Gohlke, Rachel C Chambers, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2016
Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary FibrosisAnne-Marie Russell, Huzaifa Adamali, Philip L Molyneaux, et al.
Respirology (Carlton, Vic.)|August 18, 2015
Role of a functional polymorphism in the F2R gene promoter in sarcoidosisManuela Platé, Phillippa J Lawson, Michael R Hill, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2002
Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndromeRichard P Marshall, Suzanne Webb, Geoffrey J Bellingan, et al.
American Journal of Respiratory and Critical Care Medicine|July 15, 2006
Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosisMichael R Hill, Anastasia Papafili, Helen Booth, et al.
Pageof 4